Gestational trophoblastic disease: What have we learned in thepast decade?
- 1 May 1990
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 162 (5) , 1286-1295
- https://doi.org/10.1016/0002-9378(90)90039-a
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT)Gynecologic Oncology, 1988
- Etoposide, methotrexate, and bleomycin in drug-resistant gestational trophoblastic diseaseGynecologic Oncology, 1986
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Hydatidiform Mole in a Danish Material Morphology and Cytogenetics A Preliminary CommunicationActa Radiologica: Oncology, 1984
- Application of DNA analysis to mapping the human genomeCytogenetic and Genome Research, 1982
- Anti-tumour activity of the epipodophyllin derivative VP16–213 (etoposide: NSC-141540) in gestational choriocarcinomaPublished by Elsevier ,1980
- EPIPODOPHYLLIN DERIVATIVE (VP 16-213) IN MALIGNANT TERATOMAS AND CHORIOCARCINOMASThe Lancet, 1977
- HYDATIDIFORM MOLE: TWO ENTITIESThe Lancet, 1976
- Human chorionic gonadotropin: Amino acid sequence of the α and β subunitsBiochemical and Biophysical Research Communications, 1972
- Dissociation and recombination of the subunits of human chorionic gonadotropinBiochemical and Biophysical Research Communications, 1970